We report here the draft genome sequence of an NDM-1-producing Acinetobacter bereziniae clinical strain, HPC229. This strain harbors both plasmid and chromosomal resistance determinants toward different ␤-lactams and aminoglycosides as well as several types of multidrug efflux pumps, most likely representing an adaptation strategy for survival under different environments. 
cinetobacter bereziniae is isolated primarily from clinical specimens and health care-associated environments (1) . Although most A. bereziniae isolates are susceptible to antimicrobials (2) , clinical strains bearing metallo-beta-lactamase genes have just been reported (3) (4) (5) (6) . We recently described the sequence of a bla NDM-1 -harboring plasmid (pNDM229, KT072713.1) carried by a carbapenem-resistant A. bereziniae strain (HPC229) from Argentina (4). We report here the whole-genome sequencing (WGS) of HPC229, which constitutes the sixth A. bereziniae genome in databases. Genes involved in ␤-lactam and aminoglycoside resistance were found in the HPC229 genome. Moreover, genes involved in different efflux pump systems associated with resistance to antimicrobials and toxic compounds were identified (7, 8) . These findings support the notion that A. bereziniae represents an environmental reservoir of resistance genes of clinical relevance.
HPC229 DNA was prepared using the Wizard genomic DNA purification kit (Promega) and subjected to 454 pyrosequencing (Roche Diagnostics Corporation) at INDEAR, Rosario. Data generated were assembled using Newbler v2.9, resulting in 134 contigs, 5 of them constituting the pNDM229 plasmid (4). The remaining 129 contigs have a length of 4,596,631 bp and a GϩC content of 38.00%. Genome annotation was done using the NCBI Prokaryotic Genomes Annotation Pipeline (9) , and eight contigs were left out for being shorter than 200 bp. The RAST server was employed for subsystem classification and functional annotation (10) and then the genome was manually curated. Complementary gene identification analyses were done using Mauve (11), ISFinder (12), Res-Finder 2.1 (13), and TCDB (14) . A total of 4,124 protein-coding sequences, 4 rRNAs, and 62 tRNA genes were predicted by these analyses.
WGS analyses revealed genes associated with ␤-lactam resistance, including bla NDM-1 (4), ampC, a new bla OXA-229 -like (15) variant, and 3 other putative ␤-lactamase genes, as well as a new carO allele coding for an outer membrane protein associated with imipenem uptake (16) . Other resistance genes included aphA6 (4), and a putative phosphotransferase encoding resistance to aminoglycosides. Efflux pump-and membrane-associated transporter genes of different superfamilies included (7, 8, 14, 17) ABC (MacA, MacB); BART (Acr3); IT (ArsB); MOP (NorM, AbeM); MFS (CraA, SmvA, MFS transporter, Bcr/CflA, MFS permease); DMT (AbeS, Qace⌬1-like); MER (MerT, MerC); and RND (AdeABC, AdeIJK, AdeE, CzcABC, and CusABC). The latter operon, absent in the other A. bereziniae genomes, exhibits 95% nucleotide identity to a portion of the GI2 genomic island in A. baumannii LAC-4 (8). Downstream from cus-ABC, there are regions encompassing ISAba2, acr3, and feoAB genes, with acr3 showing the highest identity to its ortholog of A. tandoii DSM14970, whereas feoAB was identified in the A. baumannii LAC-4 GI2 immediately downstream of its cusABC operon. These observations suggest a chimeric construct in HPC229 derived from gene exchange among Acinetobacter species. WGS analyses will provide further evidence of the ability of A. bereziniae to act as a reservoir of resistance genes and may help to understand the adaptability mechanisms of Acinetobacter in response to environmental challenges.
Nucleotide sequence accession numbers. This WGS project has been deposited at DDBJ/EMBL/GenBank under the accession LKDJ00000000. We describe here the version LKDJ00000000.1.
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